TrialBreast cancer research and treatment2012

A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.

Elaina M Gartner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.